Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Neurochemistry International|February 5, 2022
Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson's modelsHai-Jun He, Xi Xiong, Shuoting Zhou, et al.CNS Neuroscience & Therapeutics|July 13, 2023
Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN frameworkXi Xiong, Haijun He, Qianqian Ye, et al.Frontiers in Cell and Developmental Biology|August 20, 2021
NAD+ in Alzheimer's Disease: Molecular Mechanisms and Systematic Therapeutic Evidence Obtained in vivoXinshi Wang, Hai-Jun He, Xi Xiong, et al.Frontiers in Aging Neuroscience|May 7, 2024
Detection of elevated levels of PINK1 in plasma from patients with idiopathic Parkinson's diseaseXianchai Hong, Yi Zheng, Jialong Hou, et al.CNS Neuroscience & Therapeutics|November 22, 2023
Identification of mitophagy-associated proteins profile as potential plasma biomarkers of idiopathic Parkinson's diseaseShuangjie Qian, Haijun He, Xi Xiong, et al.Frontiers in Aging Neuroscience|November 17, 2022
Plasma-derived phosphoglycerate mutase 5 as a biomarker for Parkinson's diseaseLiang Feng, Haijun He, Xi Xiong, et al.Frontiers in Aging Neuroscience|June 1, 2022
Lewy Body-Associated Proteins A-Synuclein (a-syn) as a Plasma-Based Biomarker for Parkinson's DiseaseXuemiao Zhao, Haijun He, Xi Xiong, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 21, 2025
NAD+-Boosters Improve Mitochondria Quality Control In Parkinson's Disease Models Via Mitochondrial UPRShuoting Zhou, Xi Xiong, Jialong Hou, et al.Cell Death & Disease|October 11, 2024
NAD+-boosting agent nicotinamide mononucleotide potently improves mitochondria stress response in Alzheimer's disease via ATF4-dependent mitochondrial UPRXi Xiong, Jialong Hou, Yi Zheng, et al.Pageof 1